The highly significant decrease in iNOS+ ring cell accumulation kinetic was accompanied by an enhancement of tumor-resident CD8+ T-cell quantity in both of the iNOS inhibitor-treated groups (Figure 4D). Here, CD8A is linked to neoplasm.